首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): study protocol for a multicentre pragmatic patient-randomised non-inferiority trial
【2h】

ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): study protocol for a multicentre pragmatic patient-randomised non-inferiority trial

机译:预防性抗生素治疗女性复发性尿路感染的替代药物(ALTAR):一项多中心务实患者随机非劣效性试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAt least half of all adult women will experience infective cystitis (urinary tract infection: UTI) at least once in their life and many suffer from repeated episodes. Recurrent urinary tract infection (rUTI) in adult women is usually treated with long-term, low-dose antibiotics and current national and international guidelines recommend this as the ‘gold standard’ preventative treatment. Although they are reasonably effective, long-term antibiotics can result in bacteria becoming resistant not only to the prescribed antibiotic but to other antimicrobial agents. The problem of antimicrobial resistance is recognised as a global threat and the recent drive for antibiotic stewardship has emphasised the need for careful consideration prior to prescribing antibiotics. This has led clinicians and patients alike to explore potential non-antibiotic options for recurrent UTI prevention.
机译:背景技术所有成年女性中至少有一半一生中至少会经历一次感染性膀胱炎(尿路感染:UTI),许多人会反复发作。成年女性复发性尿路感染(rUTI)通常使用长期,低剂量的抗生素治疗,目前的国家和国际准则建议将其作为“黄金标准”预防性治疗。尽管它们是相当有效的,但长期使用抗生素可能会导致细菌不仅对处方抗生素产生耐药性,而且对其他抗菌剂也产生耐药性。抗菌素耐药性问题被认为是全球性威胁,最近对抗生素管理的推动强调了在开抗生素前必须仔细考虑的必要性。这导致临床医生和患者都在探索潜在的非抗生素治疗方法来预防复发性UTI。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号